title: Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?
authors.affiliation: Department of Gastroenterology, University of Tsukuba, Tsukuba, Japan. t.yamada718@md.tsukuba.ac.jp.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Yamada
authors.affiliation: Department of Gastroenterology, University of Tsukuba, Tsukuba, Japan.
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Yamamoto
authors.affiliation: Department of Gastroenterology, University of Tsukuba, Tsukuba, Japan.
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Moriwaki
authors.affiliation: Department of Gastroenterology, University of Tsukuba, Tsukuba, Japan.
authors.forename: Ichisnosuke
authors.initials: I
authors.lastname: Hyodo
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D006801:Humans; D013274:Stomach Neoplasms / Q000188:drug therapy*; D000068878:Trastuzumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D000068878:Trastuzumab